GAMMAGARD S/D for Immunodeficiency common variable: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where GAMMAGARD S/D was used for Immunodeficiency common variable.
Most Reported Side Effects for GAMMAGARD S/D
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 7 | 14.0% | 0 | 2 |
| Pyrexia | 7 | 14.0% | 0 | 3 |
| Transplant rejection | 5 | 10.0% | 0 | 0 |
Other Indications for GAMMAGARD S/D
Product used for unknown indication (12)
Prophylaxis against transplant rejection (10)
Off label use (6)
Hypogammaglobulinaemia (5)
Other Drugs Used for Immunodeficiency common variable
HUMAN IMMUNOGLOBULIN G (17,389)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (1,598)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (881)
GAMMAGARD LIQUID (81)
HIZENTRA (76)
DUPILUMAB (69)
RITUXIMAB (44)
INFLIXIMAB (28)
PREDNISOLONE (27)
HUMAN C1-ESTERASE INHIBITOR (24)